Purpose: To investigate the alleged insensitivity of the EuroQol (EQ5D).
Methods: Longitudinal EQ5D and visual analogue scale (VAS) data were obtained from two studies on palliative radiotherapy in patients with painful bone metastases (n=1023) or non-small-cell lung cancer (n=247). Group differences on the five EQ5D domains, three EQ5D tariffs (
Results: Over the last year, the
Conclusions: In our study the EuroQol proved sensitive to the approach of death and was able to distinguish most investigated subgroups. Moreover, it was consistently more sensitive to group differences than the VAS.